Atorva 10 (Atorvastatin) vs Rosuvas 10 (Rosuvastatin): Cholesterol Reduction Comparison
Compare Atorva 10 and Rosuvas 10: LDL cholesterol reduction potency, triglyceride lowering, muscle ache (myopathy) risks, and generic pricing in India.
Atorva contains Atorvastatin (10mg) and Rosuvas contains Rosuvastatin (10mg). Both are HMG-CoA reductase inhibitor statins. Milligram for milligram, Rosuvastatin 10mg is roughly 25-30% more potent at lowering LDL 'bad' cholesterol and raising HDL 'good' cholesterol than Atorvastatin 10mg. Both reduce heart attack and stroke risk.
1. Lipid-Lowering Potency & Hydrophilicity
Rosuvastatin is hydrophilic (water-soluble) and cleared primarily by kidneys, while Atorvastatin is lipophilic (fat-soluble) and metabolized by the liver CYP3A4 pathway. Because of this, Rosuvastatin has fewer food interactions (such as with grapefruit).
2. Statin-Associated Muscle Symptoms (SAMS)
About 5-10% of patients experience dull aching or weakness in thighs, calves, or shoulders. If muscle aches develop, doctors check serum Creatine Kinase (CK) levels to rule out muscle inflammation.
3. Jan Aushadhi Generic Savings
Branded Atorva 10 costs ~₹140 for 10 tablets; Jan Aushadhi generic Atorvastatin 10mg is ₹12.00 (91% savings). Branded Rosuvas 10 costs ~₹220; generic Rosuvastatin 10mg is ₹18.00 (91% savings).
Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison
Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.
| Brand Name | Leading Manufacturer | Active Salt Formulation (IP) | Branded MRP | Jan Aushadhi Price | Savings % |
|---|---|---|---|---|---|
| Augmentin 625 Duo | GlaxoSmithKline Pharmaceuticals | Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP | ₹220.00 | ₹58.00 | 74% |
| Dolo 650 | Micro Labs Ltd | Paracetamol (Acetaminophen) 650mg IP | ₹34.00 | ₹5.50 | 84% |
| Pantocid 40 | Sun Pharmaceutical Industries | Pantoprazole Sodium 40mg IP (Gastro-resistant) | ₹155.00 | ₹8.00 | 95% |
| Azithral 500 | Alembic Pharmaceuticals | Azithromycin Dihydrate 500mg IP | ₹132.00 | ₹24.00 | 82% |
| Glycomet 500 | USV Private Limited | Metformin Hydrochloride 500mg IP | ₹24.00 | ₹4.50 | 81% |
| Shelcal 500 | Torrent Pharmaceuticals | Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP | ₹134.00 | ₹16.00 | 88% |
| Telma 40 | Glenmark Pharmaceuticals | Telmisartan 40mg IP | ₹92.00 | ₹7.50 | 92% |
| Montair-LC | Cipla Ltd | Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP | ₹210.00 | ₹18.00 | 91% |
| Combined 8-Drug Essential Therapy Basket Total: | ₹1,001.00 | ₹141.00 | 85.9% Net Savings | ||
Frequently Asked Questions (Clinical & Regulatory)
Q1: Why should statins be taken at bedtime?
The liver synthesizes the vast majority of cholesterol overnight between midnight and 4 AM. Taking statins in the evening provides peak drug levels when cholesterol synthesis is highest.
Q2: Can taking statins trigger diabetes?
Statins can cause a very minor elevation in HbA1c (around 0.1%), but the cardiovascular lifesaving benefit of preventing heart attacks far outweighs this risk.
Q3: What is the clinical danger of abruptly stopping blood pressure medications like Telmisartan or Amlodipine?
Sudden discontinuation of antihypertensives can precipitate acute rebound hypertension, hypertensive encephalopathy, acute coronary syndrome, or cerebrovascular accident. Dose titrations must always be conducted under structured clinical supervision.
Q4: Are Jan Aushadhi generic cardiovascular medicines bioequivalent to branded drugs like Telma 40?
Yes. Jan Aushadhi Telmisartan 40mg and Amlodipine 5mg tablets satisfy CDSCO dissolution, content uniformity, and bioavailability requirements, costing ₹7.50 compared to ₹92.00 for branded retail packages.
Q5: Why are ACE inhibitors and Angiotensin Receptor Blockers (ARBs) contraindicated in pregnancy?
Telmisartan, Losartan, and Enalapril are fetotoxic, causing fetal renal dysgenesis, oligohydramnios, neonatal anuria, and calvarial hypoplasia when administered during the second and third trimesters of pregnancy.
This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.
Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.